Where to Buy PT-141 (Bremelanotide) for Research (2026)
Shop Our Top Compounds
Where to Buy PT-141 (Bremelanotide) for Research (2026 Guide)
PT-141, known by its chemical name bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist that has become an important tool compound in neuroscience, hypothalamic biology, and POMC pathway research. As interest in melanocortin receptor pharmacology continues to grow, so does demand for research-grade PT-141 from suppliers who can reliably deliver verified purity, analytical documentation, and domestic shipping.
This guide covers what PT-141 is, the research contexts in which it is studied, what to look for in a supplier, and why Iron Peak Peptides is a leading choice for US-based research teams.
What Is PT-141 (Bremelanotide)?
PT-141 (bremelanotide) is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Its chemical structure derives from melanotan II, from which the C-terminal amide was modified to produce a lactam-stabilized cyclic compound with improved metabolic stability compared to its linear precursors.
PT-141 is a non-selective melanocortin receptor agonist with notable activity at MC3R (melanocortin 3 receptor) and MC4R (melanocortin 4 receptor), both of which are expressed in the central nervous system and are subjects of active neuroscience research.
A pharmaceutical form of bremelanotide (Vyleesi®) received FDA approval in 2019 for hypoactive sexual desire disorder in premenopausal women. It is important to note that research-grade PT-141 is entirely distinct from the pharmaceutical product Vyleesi®—research-grade PT-141 is produced for preclinical laboratory investigation, not for pharmaceutical or clinical use.
Key Research Areas for PT-141
- Melanocortin receptor pharmacology: PT-141 serves as a reference agonist in studies characterizing MC3R and MC4R binding, receptor activation kinetics, and downstream cAMP signaling cascades. Its selectivity profile makes it a useful tool for receptor subtype research.
- CNS and hypothalamic research: MC3R and MC4R are highly expressed in hypothalamic nuclei involved in energy homeostasis, autonomic regulation, and reward. Preclinical studies have used PT-141 to investigate these receptor populations’ roles in central nervous system biology.
- POMC pathway studies: The proopiomelanocortin (POMC) pathway generates multiple melanocortin peptides. PT-141’s agonist activity at MC3R/MC4R makes it valuable for researchers studying downstream POMC signaling effects in animal models.
- Sexual neuroscience research: Published preclinical studies in rodent models have investigated the neural circuits through which melanocortin receptor activation influences behavioral outcomes, contributing to understanding of central regulatory pathways.
- Energy homeostasis and metabolic research: MC4R in particular has been extensively studied for its role in energy balance regulation. PT-141’s pharmacological profile makes it relevant to researchers studying hypothalamic circuits governing metabolic homeostasis.
What Researchers Look for in a PT-141 Supplier
The research peptide market encompasses suppliers ranging from rigorous, documentation-focused operations to sources that offer no analytical verification whatsoever. For compounds used in serious preclinical research, quality standards matter. Researchers evaluating PT-141 suppliers should prioritize:
Purity Verification by HPLC and Mass Spectrometry
PT-141 is a cyclic peptide, and its synthesis presents greater complexity than linear peptides. Purity verification by HPLC should confirm ≥99% purity, and mass spectrometry should confirm the correct molecular mass, distinguishing the authentic compound from synthetic impurities or degradation products.
Batch-Specific quality documentation Documentation
Batch-specific quality assurance documentation (COAs) from qualified laboratories provide the analytical backbone of research-grade procurement. Researchers should be able to access the quality documentation for the specific batch they receive—not a generic document for a different lot. Suppliers should make COAs available upon request or include them with the shipment.
Third-Party Laboratory Testing
Third-party testing removes conflicts of interest from quality reporting. An independent laboratory has no incentive to inflate purity data, making third-party HPLC and MS results more reliable than self-reported in-house testing alone.
US-Based Domestic Shipping
Domestic suppliers offer meaningful practical advantages: faster delivery, predictable lead times, no international customs delays, and commercial recourse under US law. For research programs with active experimental timelines, these factors matter.
Research-Only Framing
Suppliers must clearly designate PT-141 for research use only. Any supplier marketing research peptides for human consumption is operating inappropriately and should be avoided—both for ethical reasons and because such practices signal a disregard for regulatory standards that extends to product quality.
Why Iron Peak Peptides for PT-141 Research
Iron Peak Peptides is a US-based research peptide supplier committed to providing verified research-grade compounds to the scientific community. For researchers sourcing PT-141, IronPeak offers:
- ≥99% purity: PT-141 is verified at ≥99% purity by HPLC, meeting the analytical standard expected for rigorous preclinical research applications.
- Third-party tested: Independent laboratory analysis confirms purity and molecular identity, providing objective quality assurance beyond in-house claims.
- Batch-specific quality documentation included with shipment: Each order includes quality documentation documentation specific to the batch received, supporting experimental documentation and reproducibility records.
- Fast US-based shipping: Domestic fulfillment means orders arrive quickly, with no exposure to international customs delays that can disrupt research schedules.
- Research-only designation: IronPeak clearly designates all products as for research use only, maintaining appropriate commercial and regulatory boundaries.
- Responsive customer support: The IronPeak team is available to address product specification questions, order inquiries, and documentation requests.
Red Flags to Avoid When Sourcing PT-141
Given PT-141’s profile as both an active research compound and a substance associated with a pharmaceutical product, the market includes suppliers whose practices fall short of research-grade standards. Watch for these warning signs:
- No quality documentation available: If a supplier cannot provide analytical documentation for the product, there is no basis for trusting purity or identity claims. This is a fundamental disqualifier for research procurement.
- Overseas-only suppliers: International sourcing introduces customs unpredictability, longer shipping windows, and limited recourse. For time-sensitive research programs, this is a significant operational liability.
- No independent third-party testing: Suppliers relying entirely on self-reported quality data without third-party verification offer no independent check on their claims.
- Human use framing: Suppliers who frame research peptides for human consumption should be avoided entirely. This practice raises serious regulatory and safety concerns and indicates a supplier operating outside legitimate research-grade markets.
- Inconsistent or vague purity specifications: Listings that claim “high purity” without specifying analytical methods or percentage figures are not credible sourcing options for research applications.
- No customer support: Unreachable suppliers leave researchers with no recourse for product questions, order issues, or documentation requests.
Frequently Asked Questions
What is the difference between research-grade PT-141 and the pharmaceutical product Vyleesi®?
Vyleesi® (bremelanotide injection) is an FDA-approved pharmaceutical product manufactured under GMP conditions and approved for a specific clinical indication. Research-grade PT-141 is a distinct product manufactured for preclinical laboratory investigation—it is not a pharmaceutical product, is not intended for human use, and is not subject to the same regulatory pathway as approved drugs. The two should not be conflated. Researchers using PT-141 as a tool compound in preclinical studies are working with the research-grade compound in controlled laboratory settings.
What purity standard is appropriate for PT-141 in receptor binding and CNS research?
For receptor binding assays, cell-based signaling studies, and in vivo animal model experiments, ≥99% purity confirmed by HPLC is the appropriate benchmark. Impurities in cyclic peptides can include synthetic byproducts or degradation products that may interact with receptors non-specifically, introducing confounders into assay results. HPLC purity data combined with MS molecular identity confirmation provides the strongest quality foundation for research use.
How should research-grade PT-141 be stored to maintain integrity?
Lyophilized PT-141 powder should be stored at –20°C in a sealed container, protected from light and moisture. Under these conditions, lyophilized peptide remains stable for extended periods. After reconstitution with bacteriostatic water or another appropriate diluent, the solution should be stored at 2–8°C and used within the timeframe supported by available stability documentation. Freeze-thaw cycling should be minimized by preparing aliquots of reconstituted solution for single-use research sessions.
Is quality documentation documentation available for specific PT-141 batches from Iron Peak Peptides?
Yes. Iron Peak Peptides provides batch-specific quality assurance documentation that are included with shipment. COAs confirm HPLC purity and molecular identity for the specific batch received. Researchers may also request quality documentation documentation directly by contacting IronPeak’s support team.
Source Research-Grade PT-141 from a Trusted US Supplier
For laboratories conducting melanocortin receptor research, CNS pharmacology studies, POMC pathway investigation, or hypothalamic biology research, access to consistently high-purity PT-141 is essential. Iron Peak Peptides delivers ≥99% purity, third-party tested PT-141 with batch-specific quality documentation documentation and fast US domestic shipping.
Browse Iron Peak Peptides’ research catalog and order PT-141 for your next study →
This content is intended for research purposes only. Iron Peak Peptides products are not for human consumption. Not a drug, supplement, or medical device.
🔬 Explore Research Peptides
- Ipamorelin 10mg — $52.99
- Cartalax 20mg — $55.00
- BPC-157 500mcg x 60 Capsules — $89.00
- Tesamorelin + Ipamorelin 11mg/6mg (17mg) — $89.00
